CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants

Affiliations

• ¹ Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
• ² German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
• ³ Edmond J. Safra Fellow in Movement Disorders, New York, NY, USA.
• ⁴ Department of Molecular Medicine, University of Pavia, Pavia, Italy.
• ⁵ IRCCS Mondino Foundation, Pavia, Italy.
• ⁶ Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
• ⁷ Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Network center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
• ⁸ Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
• ⁹ Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
• ¹⁰ ESCAPE Bio, South San Francisco, CA, USA.
• ¹¹ Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. [email protected].
• ¹² German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany. [email protected].